Balyasny Asset Management
CINC

Balyasny Asset Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Balyasny Asset Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,461
Closed -$325K – 3384
2022
Q4 		$325K Buy
+26,461
New +$631K ﹤0.01% 1967

Balyasny Asset Management's CINC Position: Q1 2023 in Review

Balyasny Asset Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 26,461 shares — an estimated $325K sold.

Balyasny Asset Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $325K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Balyasny Asset Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 26,461 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $325K.
  • Balyasny Asset Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Balyasny Asset Management's CinCor Pharma, Inc. Common Stock position peaked at $325K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.